Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Upgrades Amgen to Equal-Weight, Raises Price Target to $300

Author: Benzinga Newsdesk | May 03, 2024 10:10am
Barclays analyst Carter Gould upgrades Amgen (NASDAQ:AMGN) from Underweight to Equal-Weight and raises the price target from $230 to $300.

Posted In: AMGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist